{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T04:32:52Z","timestamp":1780720372850,"version":"3.54.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"39","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.vaccine.2008.07.028","type":"journal-article","created":{"date-parts":[[2008,8,4]],"date-time":"2008-08-04T13:45:30Z","timestamp":1217857530000},"page":"5022-5029","source":"Crossref","is-referenced-by-count":14,"title":["Evaluation of recombinant Onchocerca volvulus activation associated protein-1 (ASP-1) as a potent Th1-biased adjuvant with a panel of protein or peptide-based antigens and commercial inactivated vaccines"],"prefix":"10.1016","volume":"26","author":[{"given":"Wenjun","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanying","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shibo","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Lustigman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxian","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2008.07.028_bib1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1574-695X.2001.tb00535.x","article-title":"CpG ODN can re-direct the Th bias of established Th2 immune responses in adult and young mice","volume":"32","author":"Weeratna","year":"2001","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2008.07.028_bib2","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.0818-9641.2004.01272.x","article-title":"Vaccine adjuvants: current state and future trends","volume":"82","author":"Petrovsky","year":"2004","journal-title":"Immunol Cell Biol"},{"issue":"8","key":"10.1016\/j.vaccine.2008.07.028_bib3","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S1567-5769(03)00011-0","article-title":"Adjuvants for vaccines, a quest","volume":"3","author":"Audibert","year":"2003","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"10.1016\/j.vaccine.2008.07.028_bib4","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1586\/14760584.6.3.391","article-title":"Smart adjuvants","volume":"6","author":"Schmidt","year":"2007","journal-title":"Expert Rev Vaccines"},{"issue":"13","key":"10.1016\/j.vaccine.2008.07.028_bib5","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/S1286-4579(02)00007-2","article-title":"Vaccination of mice against invasive aspergillosis with recombinant Aspergillus proteins and CpG oligodeoxynucleotides as adjuvants","volume":"4","author":"Bozza","year":"2002","journal-title":"Microb Infect"},{"issue":"27\u201330","key":"10.1016\/j.vaccine.2008.07.028_bib6","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1016\/S0264-410X(03)00437-7","article-title":"Safety and efficacy of CpG-containing oligodeoxynucleotides as immunological adjuvants in rabbits","volume":"21","author":"Ioannou","year":"2003","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2008.07.028_bib7","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.vaccine.2005.09.046","article-title":"A preliminary evaluation of alternative adjuvants to alum using a range of established and new generation vaccine antigens","volume":"24","author":"Singh","year":"2006","journal-title":"Vaccine"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2008.07.028_bib8","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ijpara.2007.08.008","article-title":"Gender-enriched transcription of activation associated secreted proteins in Ostertagia ostertagi","volume":"38","author":"Visser","year":"2008","journal-title":"Int J Parasitol"},{"issue":"5","key":"10.1016\/j.vaccine.2008.07.028_bib9","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1086\/381901","article-title":"Cloning, yeast expression, isolation, and vaccine testing of recombinant Ancylostoma-secreted protein (ASP)-1 and ASP-2 from Ancylostoma ceylanicum","volume":"189","author":"Goud","year":"2004","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2008.07.028_bib10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1365-3024.2007.01001.x","article-title":"Vaccine testing of a recombinant activation-associated secreted protein (ASP1) from Ostertagia ostertagi","volume":"30","author":"Geldhof","year":"2008","journal-title":"Parasite Immunol"},{"issue":"26","key":"10.1016\/j.vaccine.2008.07.028_bib11","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1016\/j.vaccine.2005.01.098","article-title":"rOv-ASP-1, a recombinant secreted protein of the helminth Onchocerca volvulus, is a potent adjuvant for inducing antibodies to ovalbumin. HIV-1 polypeptide and SARS-CoV peptide antigens","volume":"23","author":"MacDonald","year":"2005","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2008.07.028_bib12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.0141-9838.2004.00685.x","article-title":"Ov-ASP-1, the Onchocerca volvulus homologue of the activation associated secreted protein family is immunostimulatory and can induce protective anti-larval immunity","volume":"26","author":"MacDonald","year":"2004","journal-title":"Parasite Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2008.07.028_bib13","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1211\/jpp.58.6.0006","article-title":"HIV-1 neutralizing antibodies elicited by the candidate CBD1 epitope vaccine react with the conserved caveolin-1 binding motif of viral glycoprotein gp41","volume":"58","author":"Rey-Cuille","year":"2006","journal-title":"J Pharm Pharmacol"},{"issue":"4","key":"10.1016\/j.vaccine.2008.07.028_bib14","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.vaccine.2006.08.013","article-title":"Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity","volume":"25","author":"Huleatt","year":"2007","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2008.07.028_bib15","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1189\/jlb.0604330","article-title":"Orally administered OVA\/CpG-ODN induces specific mucosal and systemic immune response in young and aged mice","volume":"77","author":"Alignani","year":"2005","journal-title":"J Leukoc Biol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.07.028_bib16","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.virol.2005.01.042","article-title":"Neutralizing antibody and protective immunity to SARS coronavirus infection of mice induced by a soluble recombinant polypeptide containing an N-terminal segment of the spike glycoprotein","volume":"334","author":"Bisht","year":"2005","journal-title":"Virology"},{"issue":"4","key":"10.1016\/j.vaccine.2008.07.028_bib17","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.4049\/jimmunol.177.4.2552","article-title":"Subunit recombinant vaccine protects against monkeypox","volume":"177","author":"Heraud","year":"2006","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2008.07.028_bib18","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.vaccine.2006.10.009","article-title":"A protein-based smallpox vaccine protects mice from vaccinia and ectromelia virus challenges when given as a prime and single boost","volume":"25","author":"Xiao","year":"2007","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2008.07.028_bib19","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jmb.2005.04.066","article-title":"Structure-based design of a second-generation Lyme disease vaccine based on a C-terminal fragment of Borrelia burgdorferi OspA","volume":"350","author":"Koide","year":"2005","journal-title":"J Mol Biol"},{"issue":"1","key":"10.1016\/j.vaccine.2008.07.028_bib20","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.chroma.2006.09.067","article-title":"Development of recombinant protein-based influenza vaccine expression and affinity purification of H1N1 influenza virus neuraminidase","volume":"1136","author":"Dalakouras","year":"2006","journal-title":"J Chromatogr A"},{"issue":"23","key":"10.1016\/j.vaccine.2008.07.028_bib21","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1016\/j.vaccine.2007.03.051","article-title":"A new vaccine adjuvant (BOS 2000) a potent enhancer mixed Th1\/Th2 immune responses in mice immunized with HBsAg","volume":"25","author":"Khajuria","year":"2007","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2008.07.028_bib22","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/nri1183","article-title":"Immune regulation by helminth parasites: cellular and molecular mechanisms","volume":"3","author":"Maizels","year":"2003","journal-title":"Nat Rev"},{"issue":"3","key":"10.1016\/j.vaccine.2008.07.028_bib23","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1574-695X.2007.00325.x","article-title":"Adjuvant effect of CIA07, a combination of Escherichia coli DNA fragments and modified lipopolysaccharides, on the immune response to hepatitis B virus surface antigen","volume":"51","author":"Song","year":"2007","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"6","key":"10.1016\/j.vaccine.2008.07.028_bib24","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1080\/02652040701443700","article-title":"Enhancement of immune response of HBsAg loaded poly (l-lactic acid) microspheres against hepatitis B through incorporation of alum and chitosan","volume":"24","author":"Pandit","year":"2007","journal-title":"J Microencapsul"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08009729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08009729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T23:37:13Z","timestamp":1709163433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08009729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":24,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0264410X08009729"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.07.028","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}